Literature DB >> 25504269

Catheter ablation of atrial fibrillation in patients with atrial septal defect: long-term follow-up results.

Jun-Gang Nie1, Jian-Zeng Dong, Mohamed Salim, Song-Nan Li, Xiao-Yan Wu, Ying-Wei Chen, Rong Bai, Nian Liu, Xin Du, Chang-Sheng Ma.   

Abstract

INTRODUCTION: Atrial fibrillation (AF) is commonly found in patients with structural heart disease (SHD), including atrial septal defect (ASD). The feasibility and safety of ablation for AF in patients with unrepaired ASD is seldom reported.
OBJECTIVES: This study aims to evaluate and compare the long-term efficacy of AF ablation in patients with and without ASD.
METHODS: From January 2008 to December 2012, 18 consecutive patients were identified with medically refractory AF and an unrepaired ASD under catheter ablation. For each ASD patient, four control subjects were matched from our database.
RESULTS: There were no significant differences between groups in terms of age, sex, type of AF, LA diameter, LVIDD, and EF. The mean procedural and fluoroscopy times were not different between the groups (p = NS). After a median follow-up of 20 months, the patients in the ASD group had 44.4 % AF recurrence after a single procedure compared with 34.7 % in the control group (p = 0.11). The mean LA diameter in non-recurrent patients was smaller than in recurrent patients (p = 0.03). In univariate Cox proportional hazards analyses, the factor found to have a significant association with arrhythmia recurrences was left atrial diameter (hazard ratio 1.059, 95 % confidence interval 1.002 to 1.120, p = 0.03).
CONCLUSIONS: These results indicate that in patients with AF and an ASD amenable to percutaneous closure, a staged approach with radiofrequency ablation of AF preceding closure is a rational strategy.

Entities:  

Mesh:

Year:  2014        PMID: 25504269     DOI: 10.1007/s10840-014-9958-z

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  18 in total

1.  Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.

Authors:  Christian Spies; Abha Khandelwal; Ines Timmermanns; Rainer Schräder
Journal:  Am J Cardiol       Date:  2008-07-17       Impact factor: 2.778

2.  Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices.

Authors:  Pasquale Santangeli; Luigi Di Biase; J David Burkhardt; Rodney Horton; Javier Sanchez; Shane Bailey; Jason D Zagrodzky; Dhanunjaya Lakkireddy; Rong Bai; Prasant Mohanty; Salwa Beheiry; Richard Hongo; Andrea Natale
Journal:  Heart Rhythm       Date:  2011-06-22       Impact factor: 6.343

3.  Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery.

Authors:  F Berger; M Vogel; A Kramer; V Alexi-Meskishvili; Y Weng; P E Lange; R Hetzer
Journal:  Ann Thorac Surg       Date:  1999-07       Impact factor: 4.330

4.  Closure of secundum atrial septal defects in the adult and elderly patients.

Authors:  Camilla Nyboe; Morten Fenger-Grøn; Jens Erik Nielsen-Kudsk; Vibeke Hjortdal
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-14       Impact factor: 4.191

5.  Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease.

Authors:  Femi Philip; Kamran I Muhammad; Shikar Agarwal; Andrea Natale; Richard A Krasuski
Journal:  Congenit Heart Dis       Date:  2012-04-02       Impact factor: 2.007

6.  Single-catheter technique for pulmonary vein antrum isolation: is it sufficient to identify and close the residual gaps without a circular mapping catheter?

Authors:  Jianzeng Dong; Xingpeng Liu; Deyong Long; Ronghui Yu; Ribo Tang; Fei Lü; Changsheng Ma
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-13

7.  Intracardiac echo-guided radiofrequency catheter ablation of atrial fibrillation in patients with atrial septal defect or patent foramen ovale repair: a feasibility, safety, and efficacy study.

Authors:  Dhanunjaya Lakkireddy; Umamahesh Rangisetty; Subramanya Prasad; Atul Verma; Mazda Biria; Loren Berenbom; Rhea Pimentel; Martin Emert; Thomas Rosamond; Tamer Fahmy; Dimpi Patel; Luigi Di Biase; Robert Schweikert; David Burkhardt; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2008-07-25

8.  Fate of preoperative atrial fibrillation after correction of atrial septal defect.

Authors:  Jin Wi; Jae-Young Choi; Jae-Min Shim; Jae-Sun Uhm; Hye-Jin Hwang; Jong-Youn Kim; Hui-Nam Pak; Boyoung Joung; Moonhyoung Lee
Journal:  Circ J       Date:  2012-10-16       Impact factor: 2.993

9.  Reentrant and focal activations during atrial fibrillation in patients with atrial septal defect.

Authors:  Takashi Nitta; Shun-Ichiro Sakamoto; Yasuo Miyagi; Masahiro Fujii; Yosuke Ishii; Masami Ochi
Journal:  Ann Thorac Surg       Date:  2013-08-21       Impact factor: 4.330

Review 10.  Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis.

Authors:  Joshua A Vecht; Srdjan Saso; Christopher Rao; Konstantinos Dimopoulos; Julia Grapsa; Cesare M Terracciano; Nicholas S Peters; Petros Nihoyannopoulos; Elaine Holmes; Michael A Gatzoulis; Thanos Athanasiou
Journal:  Heart       Date:  2010-11       Impact factor: 5.994

View more
  7 in total

1.  Ablation of Atrial Fibrillation in Patients with Congenital Heart Disease.

Authors:  Marwan M Refaat; Jad Ballout; Moussa Mansour
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

2.  Pulmonary vein isolation for paroxysmal atrial fibrillation in a patient with stand-alone unroofed coronary sinus.

Authors:  Masaki Tsuji; Ken Kato; Hiroyuki Tanaka; Tamotsu Tejima
Journal:  HeartRhythm Case Rep       Date:  2017-02-20

3.  Successful Percutaneous Retrieval of Embolized Septal Occluder Device from Aortic Arch and Placement of a Newer Septal Occluder Device in Combined Procedure.

Authors:  Natraj Katta; Sandeep Gautam; Richard Webel
Journal:  Case Rep Cardiol       Date:  2016-12-27

4.  The influence of iatrogenic atrial septal defect on the prognosis of patients with atrial fibrillation between cryoablation and radiofrequency ablation.

Authors:  Ying Yang; Jinglan Wu; Lixia Yao; Yue Liu; Chenfeng Zhang; Ling You; Jing Yang; Ruiqin Xie
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

5.  Concomitant pulmonary vein isolation and percutaneous closure of atrial septal defects: A pilot project.

Authors:  Reinder Evertz; Charlotte A Houck; Tim Ten Cate; Anthonie L Duijnhouwer; Rypko Beukema; Sjoerd Westra; Kevin Vernooy; Natasja M S de Groot
Journal:  Congenit Heart Dis       Date:  2019-11-06       Impact factor: 2.007

6.  Atrial fibrillation in patients with an atrial septal defect in a single centre cohort during a long clinical follow-up: its association with closure and outcome of therapy.

Authors:  Reinder Evertz; Manon Reinders; Charlotte Houck; Tim Ten Cate; Anthonie L Duijnhouwer; Rypko Beukema; Sjoerd Westra; Kevin Vernooy; Natasja M S de Groot
Journal:  Open Heart       Date:  2020-08

7.  Atrial tachyarrhythmias following percutaneous device closure of secundum atrial septal defects.

Authors:  Vishal Vyas; Amit Kaura; Vinit Sawhney; Martin Lowe; Vivienne Ezzat
Journal:  Int J Cardiol Heart Vasc       Date:  2020-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.